Benitec Biopharma (BNTC) Current Leases (2020 - 2025)
Historic Current Leases for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to $346000.0.
- Benitec Biopharma's Current Leases rose 1849.32% to $346000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $346000.0, marking a year-over-year increase of 1849.32%. This contributed to the annual value of $284000.0 for FY2024, which is 327.27% up from last year.
- Latest data reveals that Benitec Biopharma reported Current Leases of $346000.0 as of Q1 2025, which was up 1849.32% from $137000.0 recorded in Q4 2024.
- Over the past 5 years, Benitec Biopharma's Current Leases peaked at $346000.0 during Q1 2025, and registered a low of $137000.0 during Q4 2024.
- In the last 5 years, Benitec Biopharma's Current Leases had a median value of $258000.0 in 2022 and averaged $247823.5.
- Per our database at Business Quant, Benitec Biopharma's Current Leases surged by 3298.97% in 2022 and then plummeted by 5209.79% in 2024.
- Over the past 5 years, Benitec Biopharma's Current Leases (Quarter) stood at $213000.0 in 2021, then grew by 23.47% to $263000.0 in 2022, then increased by 8.75% to $286000.0 in 2023, then plummeted by 52.1% to $137000.0 in 2024, then soared by 152.55% to $346000.0 in 2025.
- Its Current Leases stands at $346000.0 for Q1 2025, versus $137000.0 for Q4 2024 and $211000.0 for Q3 2024.